Skip Ribbon Commands
Skip to main content
Sign In
{{'GLOBAL_MESSAGE_OR' | translate}}
{{'ELOQUA_BANNER_ACCEPT' | translate}}
{{'ELOQUA_BANNER_DECLINE' | translate}}

Cost-Benefit Analysis of Expanding Bone-Marrow-Derived Mesenchymal Stem Cells (MSCs) Using Automated Cell Expansion Methods Versus Manual Methods

This webinar evaluates different options for scaling up large quantities of bone-marrow-derived MSCs (BM-MSCs), using methods that can be performed in compliance with good manufacturing practices (GMP).Topics covered include cell yields, cost, time, effort and ease of use with either automated or manual methods to manufacture enough BM-MSCs to administer a single dose of 100 × 106 cells per patient.

In this webinar, you will learn about cost-benefit analysis for manual versus automated MSC manufacturing for phase I and II clinical trials.

About the Presenter:

Athena Russell, MT(AAB)

Lead Medical Laboratory Scientist and Assistant Professor, Mayo Clinic (Jacksonville, FL, USA)

Athena Russell is Lead Medical Laboratory Scientist of the Human Cellular Therapy Laboratory and Assistant Professor of Laboratory Medicine and Pathology at Mayo Clinic in Jacksonville, Florida. She has held multiple positions at Mayo Clinic, concentrating her work on mesenchymal and hematopoietic stem cell research, as well as other cellular and cell-derived therapies. Dr. Russell also holds elected positions with the International Society for Cellular Therapy and the American Association of Bioanalysts.

To access the webinar, please provide the following information:

Fields marked * are required.


{{'SEARCH_MODAL_TITLE' | translate }}
{{'SEARCH_MODAL_OR' | translate }}

{{'SEARCH_MODAL_BROWSE' | translate }}
{{$index+1}}. {{s.label}}